130 related articles for article (PubMed ID: 14624329)
1. Central administration of nociceptin/orphanin FQ blocks the acquisition of conditioned place preference to morphine and cocaine, but not conditioned place aversion to naloxone in mice.
Sakoori K; Murphy NP
Psychopharmacology (Berl); 2004 Mar; 172(2):129-36. PubMed ID: 14624329
[TBL] [Abstract][Full Text] [Related]
2. Mouse strain differences in opiate reward learning are explained by differences in anxiety, not reward or learning.
Dockstader CL; van der Kooy D
J Neurosci; 2001 Nov; 21(22):9077-81. PubMed ID: 11698618
[TBL] [Abstract][Full Text] [Related]
3. Endogenous opioid system modulates conditioned cocaine reward in a sex-dependent manner.
Matsumura K; Nicot A; Choi IB; Asokan M; Le NN; Natividad LA; Dobbs LK
Addict Biol; 2023 Oct; 28(10):e13328. PubMed ID: 37753570
[TBL] [Abstract][Full Text] [Related]
4. Doxycycline diminishes the rewarding and psychomotor effects induced by morphine and cocaine.
Sales AJ; Gobira PH; Pedrazzi JFC; Silveira JR; Del Bel E; Gomes FV; Guimarães FS
Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110870. PubMed ID: 37793480
[TBL] [Abstract][Full Text] [Related]
5. Effects of morphine on conditioned place preference and pain are independent of uptake‑2.
Souri MS; Alavi MS; Salami AA; Roohbakhsh A
Acta Neurobiol Exp (Wars); 2024 Mar; 84(1):26-34. PubMed ID: 38587327
[TBL] [Abstract][Full Text] [Related]
6. Pharmacological blockage of NOP receptors decreases ventral tegmental area dopamine neuronal activity through GABA
Petrella M; Borruto AM; Curti L; Domi A; Domi E; Xu L; Barbier E; Ilari A; Heilig M; Weiss F; Mannaioni G; Masi A; Ciccocioppo R
Neuropharmacology; 2024 May; 248():109866. PubMed ID: 38364970
[TBL] [Abstract][Full Text] [Related]
7. Endogenous opioid systems alterations in pain and opioid use disorder.
Higginbotham JA; Markovic T; Massaly N; Morón JA
Front Syst Neurosci; 2022; 16():1014768. PubMed ID: 36341476
[TBL] [Abstract][Full Text] [Related]
8. PPL-138 (BU10038): A bifunctional NOP/mu partial agonist that reduces cocaine self-administration in rats.
Cippitelli A; Martinez M; Zribi G; Cami-Kobeci G; Husbands SM; Toll L
Neuropharmacology; 2022 Jun; 211():109045. PubMed ID: 35378170
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of the nociceptin opioid peptide agonist Ro 64-6198 on pain-depressed behavior and heroin choice in rats.
Moerke MJ; Negus SS; Banks ML
Drug Alcohol Depend; 2022 Feb; 231():109255. PubMed ID: 34998256
[TBL] [Abstract][Full Text] [Related]
10. Role of Nociceptin/Orphanin FQ-NOP Receptor System in the Regulation of Stress-Related Disorders.
Ubaldi M; Cannella N; Borruto AM; Petrella M; Micioni Di Bonaventura MV; Soverchia L; Stopponi S; Weiss F; Cifani C; Ciccocioppo R
Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884757
[TBL] [Abstract][Full Text] [Related]
11. The Buprenorphine Analogue BU10119 Attenuates Drug-Primed and Stress-Induced Cocaine Reinstatement in Mice.
Hillhouse TM; Olson KM; Hallahan JE; Rysztak LG; Sears BF; Meurice C; Ostovar M; Koppenhaver PO; West JL; Jutkiewicz EM; Husbands SM; Traynor JR
J Pharmacol Exp Ther; 2021 Sep; 378(3):287-299. PubMed ID: 34183434
[TBL] [Abstract][Full Text] [Related]
12. The NOP Receptor System in Neurological and Psychiatric Disorders: Discrepancies, Peculiarities and Clinical Progress in Developing Targeted Therapies.
Toll L; Cippitelli A; Ozawa A
CNS Drugs; 2021 Jun; 35(6):591-607. PubMed ID: 34057709
[TBL] [Abstract][Full Text] [Related]
13. Sex differences in pregabalin-seeking like behavior in a conditioned place preference paradigm.
Alsaab HO; Altowairqi E; Alzahrani N; Alzahrani R; Alshehri FS; Almalki AH; Alsanie WF; Gaber A; Alkhalifa T; Almalki A; Shah ZA; Althobaiti YS
Saudi Pharm J; 2020 Dec; 28(12):1749-1755. PubMed ID: 33424265
[TBL] [Abstract][Full Text] [Related]
14. Differential Modulation of Ventral Tegmental Area Circuits by the Nociceptin/Orphanin FQ System.
Driscoll JR; Wallace TL; Mansourian KA; Martin WJ; Margolis EB
eNeuro; 2020; 7(5):. PubMed ID: 32747458
[TBL] [Abstract][Full Text] [Related]
15. Protagonist Role of Opioidergic System on Post-Traumatic Stress Disorder and Associated Pain.
Nikbakhtzadeh M; Borzadaran FM; Zamani E; Shabani M
Psychiatry Investig; 2020 Jun; 17(6):506-516. PubMed ID: 32492768
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse.
Kiguchi N; Ding H; Ko MC
J Neurosci Res; 2022 Jan; 100(1):191-202. PubMed ID: 32255240
[TBL] [Abstract][Full Text] [Related]
17. Molecular Imaging of Opioid and Dopamine Systems: Insights Into the Pharmacogenetics of Opioid Use Disorders.
Burns JA; Kroll DS; Feldman DE; Kure Liu C; Manza P; Wiers CE; Volkow ND; Wang GJ
Front Psychiatry; 2019; 10():626. PubMed ID: 31620026
[TBL] [Abstract][Full Text] [Related]
18. Nociceptin Receptors Upregulated in Cocaine Use Disorder: A Positron Emission Tomography Imaging Study Using [
Narendran R; Tollefson S; Himes ML; Paris J; Lopresti B; Ciccocioppo R; Mason NS
Am J Psychiatry; 2019 Jun; 176(6):468-476. PubMed ID: 31055968
[TBL] [Abstract][Full Text] [Related]
19. NOP-Related Mechanisms in Substance Use Disorders.
Ciccocioppo R; Borruto AM; Domi A; Teshima K; Cannella N; Weiss F
Handb Exp Pharmacol; 2019; 254():187-212. PubMed ID: 30968214
[TBL] [Abstract][Full Text] [Related]
20. Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.
Mann A; Moulédous L; Froment C; O'Neill PR; Dasgupta P; Günther T; Brunori G; Kieffer BL; Toll L; Bruchas MR; Zaveri NT; Schulz S
Sci Signal; 2019 Mar; 12(574):. PubMed ID: 30914485
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
